Lopez-Montesinos, I.; Montero, M.M.; Domene-Ochoa, S.; López-Causapé, C.; Echeverria, D.; SorlÃ, L.; Campillo, N.; Luque, S.; Padilla, E.; Prim, N.;
et al. Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo and In Vitro Evidence. Antibiotics 2022, 11, 1456.
https://doi.org/10.3390/antibiotics11111456
AMA Style
Lopez-Montesinos I, Montero MM, Domene-Ochoa S, López-Causapé C, Echeverria D, Sorlà L, Campillo N, Luque S, Padilla E, Prim N,
et al. Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo and In Vitro Evidence. Antibiotics. 2022; 11(11):1456.
https://doi.org/10.3390/antibiotics11111456
Chicago/Turabian Style
Lopez-Montesinos, Inmaculada, MarÃa Milagro Montero, Sandra Domene-Ochoa, Carla López-Causapé, Daniel Echeverria, Luisa SorlÃ, Nuria Campillo, Sonia Luque, Eduardo Padilla, Nuria Prim,
and et al. 2022. "Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo and In Vitro Evidence" Antibiotics 11, no. 11: 1456.
https://doi.org/10.3390/antibiotics11111456
APA Style
Lopez-Montesinos, I., Montero, M. M., Domene-Ochoa, S., López-Causapé, C., Echeverria, D., SorlÃ, L., Campillo, N., Luque, S., Padilla, E., Prim, N., Grau, S., Oliver, A., & Horcajada, J. P.
(2022). Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo and In Vitro Evidence. Antibiotics, 11(11), 1456.
https://doi.org/10.3390/antibiotics11111456
